Systematic review of 11 RCTs (9 meta-analysed): with non-titratable NRT, normal/fast nicotine metabolisers had lower odds of verified quitting than slow metabolisers (OR 0.81, 95% CI 0.68–0.96); no significant difference with titratable NRT, bupropion or varenicline.
Meta-analysisn = 11 trials
Xie et al. Role of nicotine metabolite ratio in pharmacological interventions on smoking cessation: A systematic review and meta-analyses of randomized controlled trials